Active and remitted schizophrenia: Psychopathological and regional cerebral blood flow findings

Psychiatry Research - Neuroimaging

Volumn 90, Issue 1, 1999, Pages 17-30

  Erkwoh, Ralf ^a   Sabri, Osama ^a   Willmes, Klaus ^a   Steinmeyer, Eckhard M ^b   Büll, Udalrich ^a   Saß, Henning ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Florid vs. remitted state; Positive and Negative Syndrome Scale; Psychosis; Single photon emission computed tomography

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MENTAL DISEASE; NEURORADIOLOGY; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; SCHIZOPHRENIA; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; BRAIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033593815     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(99)00005-0     Document Type: Article

References (58)

1. American Psychiatric Association, 1987. DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed., revised. American Psychiatric Press, Washington, D.C.
2. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry. 39:1982;784-788.
3. Andreasen N.C., Rezai K., Alliger R.J., Swayze V.W. III, Flaum M., Kirchner P., Cohen G., O'Leary D.S. Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Archives of General Psychiatry. 49:1992;943-958.
4. Andreasen N.C., Arndt S., Swayze V.W. II, Cizadlo T., Flaum M., O'Leary D., Ehrhardt J.C., Yuh W.T.C. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science. 266:1994;294-298.
5. Bavry, J.L., 1991. STAT-POWER (TM): Statistical Design Analysis System. Scientific Software, Inc., Copyright 1982-1998 by Microsoft Corporation.
6. Buchsbaum M.S. The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin. 16:1990;377-387.
7. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., Haier R.J., Wu J., Bunney W.E. Jr. PET and MRI of the thalamus in never-medicated patients with schizophrenia. American Journal of Psychiatry. 153:1996;191-199.
8. Buchsbaum M.S., Wu J.C., DeLisi L.E., Holcomb H.H., Hazlett E., Cooper-Langston K., Kessler R. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biological Psychiatry. 22:1987;479-494.
9. Bunney, B., Bunney, W.E., Jr., Carlsson, A., 1995. Schizophrenia and glutamate. In: Bloom F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press, New York, pp. 1205-1214.
10. Carlsson M., Carlsson A. Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin. 16:1990;425-432.
11. Carpenter W.T. Jr., Heinrichs D.W., Alphs L.D. Treatment of negative symptoms. Schizophrenia Bulletin. 1(11):1985;440-452.
12. Catafau A.M., Parellada E., Lomeña F.J., Bernardo M., Pavía J., Ros D., Setoain J., Gonzalez-Monclus E. Prefrontal and temporal blood flow in schizophrenia: resting and activation technetium-99m-HMPAO-SPECT patterns in young neuroleptic-naive patients with acute disease. Journal of Nuclear Medicine. 35:1994;935-941.
13. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science. 25:1978;638-643.
14. Chua S.E., McKenna P.J. Schizophrenia - a brain disease? British Journal of Psychiatry. 166:1995;563-582.
15. Cleghorn J.M., Garnett E.S., Nahmias C., Firnau G., Brown G.M., Kaplan R., Szechtman H., Szechtman B. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psychiatry Research. 28:1989;119-133.
16. Cohen R.M., Semple W.E., Gross M., Nordahl T.E., King A.C., Pickar D., Post R.M. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia. Neuropsychopharmacology. 2:1989;241-254.
17. DeLisi L.E., Buchsbaum M.S., Holcomb H.H., Langston K.C., King A.C., Kessler R., Pickar D., Carpenter W.T. Jr., Morihisa J.M. Increased temporal lobe glucose use in chronic schizophrenic patients. Biological Psychiatry. 25:1989;835-851.
18. Early T.S., Posner M.I., Reiman E.M., Raichle M.E. Hyperactivity of the left striato-pallidal projection: Part I. Lower level theory; Part II. Phenomenology and thought disorder. Psychiatric Developments. 2:1989;85-121.
19. 99mTc-exametazime in unmedicated schizophrenic patients. Biological Psychiatry. 33:1993;487-495.
20. Erbaş B., Kumbasar H., Erbengi G., Bekdik C. Tc-99m HMPAO/SPECT determination of regional cerebral blood flow changes in schizophrenics. Clinical Nuclear Medicine. 12:1990;904-907.
21. Erkwoh R., Sabri O., Steinmeyer E.M., Büll U., Saß H. Psychopathological and SPECT findings in never-treated schizophrenia. Acta Psychiatrica Scandinavica. 96:1997;51-57.
22. Franzén G., Ingvar D.H. Abnormal distribution of cerebral activity in chronic schizophrenia. Journal of Psychiatric Research. 12:1975;199-214.
23. Gordon E., Barry R.J., Anderson J., Fawdry R., Yong C., Grunewald S., Meares R.A. Single photon emission computed tomography (SPECT) measures of brain functions in schizophrenia. Australian and New Zealand Journal of Psychiatry. 28(2):1994;446-452.
24. Gur R.E., Mozley P.D., Resnick S.M., Mozley L.H., Shtasel D.L., Gallacher F., Arnold S.E., Karp J.S., Alavi A., Reivich M., Gur R.C. Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. Archives of General Psychiatry. 52:1995;657-667.
25. Hänsgen, K.-H. (Ed.), 1992. CORA, Computerbasiertes Ratingsystem psychopathologisch relevanter Urteilsdaten. Beltz Test GmbH, Weinheim.
26. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics. 6:1979;65-70.
27. Junck L., Gilman S., Roghley J.R., Betley A.T., Koeppe R.A., Hichwa R.D. A relationship between metabolism in frontal lobes and cerebellum in normal subjects studied with PET. Journal of Cerebral Blood Flow and Metabolism. 8:1988;774-782.
28. Kaiser H.L., Sabri O., Wagenknecht G., Lege B., Hellwig D., Büll U. A method of correlating and merging cerebral morphology and function by a special headholder. Nuclear Medicine. 33:1994;123-126.
29. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 13:1987;261-276.
30. Kretschmann, H.J., Weinrich, W., 1991. Clinical Neuroanatomy and Cranial Diagnostic Imaging, 2nd ed. Thieme, Stuttgart/New York.
31. Kurachi M., Kobayashi K., Matsubara R., Hiramatsu H., Yamaguchi N., Matsuda H., Maeda T., Hisada K. Regional cerebral blood flow in schizophrenic disorders. European Neurology. 24:1985;176-181.
32. Laberge D., Buchsbaum M.S. PET measurements of pulvinar activity during an attention task. Journal of Neuroscience. 10:1990;613-619.
33. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., Frackowiak R.S.J. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry. 160:1992;179-186.
34. Martin P., Albers M. Cerebellum and schizophrenia: a selective review. Schizophrenia Bulletin. 21(2):1995;241-251.
35. McGuire P.K., Shah G.M., Murray R.M. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet. 342:1993;703-706.
36. Mesulam, M.M., 1985. Attention, confusional states, and neglect. In: Mesulam, M.M. (Ed.), Principles in Behavioral Neurology. Davis, Philadelphia.
37. Paulman R.G., Devous M.D., Sr., Gregory R.R., Herman J.H., Jennings L., Bonte F.J., Nasrallah H.A., Raese J.D. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biological Psychiatry. 27:1990;377-399.
38. Posner M.I., Petersen S.E. The attention system of the human brain. Annual Review of Neuroscience. 13:1990;25-42.
39. Posner M.I., Petersen S.E., Fox P.T., Raichle M.E. Localization of cognitive operations in the human brain. Science. 240:1988;1627-1631.
40. Raichle M.E., Fiez J.A., Videen T.O., MacLeod A.K., Pardo J.V., Petersen S.E. Practice-related changes in human brain functional anatomy during non-motor learning. Cerebral Cortex. 4(1):1994;8-26.
41. Resnick S.M., Gur R.E., Alavi A., Gur R.C., Reivich M. Positron emission tomography and subcortical glucose metabolism in schizophrenia. Psychiatry Research. 24:1988;1-11.
42. Sabri O., Erkwoh R., Schreckenberger M., Owega A., Saß H., Büll U. Correlations of positive symptoms exclusively to either hyper- or hypoperfusion of the cerebral cortex in never-treated schizophrenics. Lancet. 349:1997;1735-1739.
43. Sabri O., Erkwoh R., Schreckenberger M., Cremerius U., Schulz G., Dickmann C., Kaiser H.J., Steinmeyer E.M., Saß H., Büll U. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive, schizophrenic patients during the acute phase and after treatment. Journal of Nuclear Medicine. 38:1997;181-188.
44. Sachs, L., 1972. Statistische Auswertungsmethoden. 3. neubearbeitete und erweiterte Aufl. mit neuer Bibliographie. Springer, Berlin/Heidelberg/New York.
45. Sandyk R., Kay S.R., Merriam A.E. Atrophy of the cerebellar vermis: relevance to the symptoms of schizophrenia. International Journal of Neuroscience. 57:1991;205-212.
46. Schröder J., Buchsbaum M.S., Siegel B.V., Geider F.J., Lohr J., Tang C., Wu J., Potkin S.G. Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia. Schizophrenia Research. 19:1996;41-53.
47. Schröder J., Buchsbaum M.S., Siegel B.V. Jr., Geider F.J., Niethammer R. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology. 28:1995;38-45.
48. 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet. 31:1983;1448-1452.
49. Syed G.M.S., Barret J.J., Toone B.K. What does rCBF SPECT offer in schizophrenia? Nuclear Medicine Communications. 13:1992;879-884.
50. Szechtman H., Nahmias C., Garnett S., Firnau G., Brown G.M., Kaplan R.D., Cleghorn J.M. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Archives of General Psychiatry. 45:1988;523-532.
51. Talairach, J., Tournoux, P., 1993. Atlas of Stereotaxic Anatomical Correlations of Gray and White Matter. Thieme, New York.
52. Tamminga C.A., Thaker G.K., Buchanan M., Kirkpatrick B., Alphs L.D., Chase T.N., Carpenter W.T. Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry. 49:1992;552-1530.
53. Volkow N.D., Wolf A.P., van Gelder P., Brodie J.D., Overall J.E., Cancro R., Gomez-Mont F. Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. American Journal of Psychiatry. 144:1987;151-158.
54. Waddington J.L. Sight and insight: regional cerebral metabolic activity in schizophrenia visualised by positron emission tomography, and competing neurodevelopmental perspectives. British Journal of Psychiatry. 156:1990;615-619.
55. Warkentin S., Nilsson A., Risberg J., Karlson S., Flekkoy K., Franzén G., Gustafson L., Rodriguez R. Regional cerebral blood flow in schizophrenia: repeated studies during a psychotic episode. Psychiatry Research: Neuroimaging. 35:1990;27-38.
56. Weinberger D.R., Kleinman J.E., Luchins D.J., Bigelow L.B., Wyatt R.J. Cerebellar pathology in schizophrenia: a controlled postmortem study. American Journal of Psychiatry. 137:1980;359-361.
57. Wiesel F.A., Wik G., Sjögren I., Blomqvist G., Greitz T., Stone-Elander S. Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates. Acta Psychiatrica Scandinavica. 76:1987;628-641.
58. Wolkin A., Sanfilipo M., Wolf A.P., Angrist B., Brodie J.D., Rotrosen J. Negative symptoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry. 49:1992;959-965.